{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:25:50Z","timestamp":1792686350040,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"am","delay-in-days":413,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009029","name":"Adaptable and Seamless Technology Transfer Program through Target-Driven R and D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.antiviral.2014.10.017","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T18:23:25Z","timestamp":1416507805000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Inhibitory effects of Pycnogenol\u00ae on hepatitis C virus replication"],"prefix":"10.1016","volume":"113","author":[{"given":"Sayeh","family":"Ezzikouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"Benjelloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Kino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tsukiyama-Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.10.017_b0005","unstructured":"American Botanical Council, 2010. Scientific and clinical monograph for Pycnogenol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1478-3231.2009.02188.x","article-title":"The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report","volume":"30","author":"Antaki","year":"2010","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2014.10.017_b0015","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1009482","article-title":"Boceprevir for previously treated chronic HCV genotype 1 infection","volume":"364","author":"Bacon","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/095632020801900104","article-title":"Combinations of 2\u2032-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system","volume":"19","author":"Bassit","year":"2008","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2014.10.017_b0025","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/taap.2000.9001","article-title":"Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7","volume":"168","author":"Cho","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0040","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/ptr.2812","article-title":"Pycnogenol inhibits immunoglobulin E-mediated allergic response in mast cells","volume":"23","author":"Choi","year":"2009","journal-title":"Phytother. Res."},{"key":"10.1016\/j.antiviral.2014.10.017_b0035","first-page":"735","article-title":"Hepatitis C virus core protein is efficiently released into the culture medium in insect cells","volume":"37","author":"Choi","year":"2004","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.antiviral.2014.10.017_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hep.23671","article-title":"Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection","volume":"52","author":"de Mochel","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.10.017_b0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7883\/yoken.JJID.2008.279","article-title":"Pycnogenol, a procyanidin-rich extract from French maritime pine, inhibits intracellular replication of HIV-1 as well as its binding to host cells","volume":"61","author":"Feng","year":"2008","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.10.017_b0060","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.1073\/pnas.171311298","article-title":"Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B","volume":"98","author":"Gong","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.10.017_b0065","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","article-title":"Peginterferon and ribavirin for chronic hepatitis C","volume":"355","author":"Hoofnagle","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hep.21587","article-title":"Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo","volume":"45","author":"Inoue","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.10.017_b0075","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0080","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2013.06.012","article-title":"A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes","volume":"145","author":"Katsume","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.10.017_b0085","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3390\/v4102251","article-title":"Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases","volume":"4","author":"Ke","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2014.10.017_b0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.virol.2012.08.029","article-title":"Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle","volume":"433","author":"Khachatoorian","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.017_b0095","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0100","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ptr.3193","article-title":"Effect of pycnogenol on glucose transport in mature 3T3-L1 adipocytes","volume":"24","author":"Lee","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.antiviral.2014.10.017_b0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-4-25","article-title":"Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy","volume":"4","author":"Levent","year":"2006","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3851\/IMP1597","article-title":"Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication","volume":"20","author":"Li","year":"2010","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2014.10.017_b0115","doi-asserted-by":"crossref","first-page":"e54466","DOI":"10.1371\/journal.pone.0054466","article-title":"Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.10.017_b0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jep.2010.10.041","article-title":"A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract","volume":"133","author":"Maimoona","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cardfail.2007.06.721","article-title":"French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis","volume":"13","author":"Matsumori","year":"2007","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.antiviral.2014.10.017_b0130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0135","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2014.10.017_b0140","doi-asserted-by":"crossref","first-page":"36442","DOI":"10.1074\/jbc.M109.043232","article-title":"Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase","volume":"284","author":"Nishimura","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.017_b0145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00535-011-0411-0","article-title":"Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients","volume":"46","author":"Ozeki","year":"2011","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0150","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0891-5849(99)00090-8","article-title":"Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol","volume":"27","author":"Packer","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jhep.2005.12.007","article-title":"The coming wave of HCV-related liver disease: dilemmas and challenges","volume":"44","author":"Perz","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0160","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.antiviral.2014.05.015","article-title":"Update on hepatitis C virus resistance to direct-acting antiviral agents","volume":"108","author":"Poveda","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.10.017_b0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biocel.2012.06.008","article-title":"Targeting mitochondria in the infection strategy of the hepatitis C virus","volume":"45","author":"Quarato","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nchembio742","article-title":"Host sphingolipid biosynthesis as a target for hepatitis C virus therapy","volume":"1","author":"Sakamoto","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0180","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1155\/2003\/710693","article-title":"Oxidative stress in chronic hepatitis C: the effect of interferon therapy and correlation with pathological features","volume":"17","author":"Serejo","year":"2003","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0185","doi-asserted-by":"crossref","first-page":"e82299","DOI":"10.1371\/journal.pone.0082299","article-title":"Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.10.017_b0190","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jhep.2010.12.011","article-title":"Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes","volume":"55","author":"Takano","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0195","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0016-5085(99)70185-X","article-title":"Real-time detection system for quantification of hepatitis C virus genome","volume":"116","author":"Takeuchi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2014.10.017_b0200","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tim.2005.02.004","article-title":"Hepatitis C virus, ER stress, and oxidative stress","volume":"13","author":"Tardif","year":"2005","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0205","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"Tateno","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0210","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.3184","article-title":"Global control of hepatitis C: where challenge meets opportunity","volume":"19","author":"Thomas","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0215","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/10715760500419357","article-title":"Ferritin oxidation and proteasomal degradation: protection by antioxidants","volume":"40","author":"Voss","year":"2006","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.antiviral.2014.10.017_b0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.10.017_b0225","doi-asserted-by":"crossref","first-page":"40778","DOI":"10.1074\/jbc.M303248200","article-title":"Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease","volume":"278","author":"Waris","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.017_b0230","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/JVI.79.3.1569-1580.2005","article-title":"Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication","volume":"79","author":"Waris","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.017_b0235","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.gt.3302734","article-title":"Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype","volume":"13","author":"Watanabe","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2014.10.017_b0240","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nutres.2008.03.003","article-title":"Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation","volume":"28","author":"Zibadi","year":"2008","journal-title":"Nutr. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:26:13Z","timestamp":1759062373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214003106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":48,"alternative-id":["S0166354214003106"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.10.017","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects of Pycnogenol\u00ae on hepatitis C virus replication","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}